Protalix Biotherapeutics Inc · Stock-Based Compensation

Latest reported$2.26Mperiod endingJun 30, 2026

PLX Stock-Based Comp ($0.00 → $2.26M)

Annual stock-based compensation

High-resolution chart · PNG

PLX stock-based compensation history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Protalix Biotherapeutics Inc Stock-Based Compensation — Annual fiscal periods (USD)
Period ending	Stock-Based Compensation (USD)
Dec 31, 2025	2,297,000
Dec 31, 2024	3,253,000
Dec 31, 2023	3,448,000
Dec 31, 2022	2,085,000
Dec 31, 2021	2,375,000
Dec 31, 2020	3,126,000
Dec 31, 2019	835,000
Dec 31, 2018	514,000
Dec 31, 2017	337,000
Dec 31, 2016	988,000
Dec 31, 2015	1,802,000
Dec 31, 2014	1,242,000
Dec 31, 2013	4,089,000
Dec 31, 2012	7,751,000
Dec 31, 2011	886,000
Dec 31, 2010	1,282,000
Dec 31, 2009	2,683,000
Dec 31, 2008	3,071,000
Dec 31, 2007	10,845,000
Dec 31, 2006	3,421,000
Dec 31, 2005	0
Dec 31, 2004	0
Dec 31, 2003	0
Dec 31, 2002	0
Dec 31, 2001	0
Dec 31, 2000	0
Dec 31, 1999	0
Dec 31, 1998	0
Dec 31, 1997	0
Dec 31, 1996	0